A Case Report of Topiramate-induced Acute Myopia
Authors
Abstract:
Acute myopia following use of some drugs is a relatively rare condition. Topiramate prescribed for seizure prophylaxis is one of these drugs. In this paper a case of acute transient myopia after taking topiramate is reported. The reported patient is a 28-year old woman who had no history of any eye disease. Following consumption of topiramate pill for one week, she had found blurred vision since one day prior to the admission. A complete ocular examinations revealed acute bilateral myopia. This disease was resolved about 48 hours after discontinuation of topiromate. Due to the wide spectrum of indications for the administration of Topiramate, neurologists and psychiatrists should be aware of its ocular side effects. In conclusion, ocular complications following this drug should be taken seriously and be subjected to ophthalmic counsaltation
similar resources
A Case Report on Topiramate Induced Myopia
This is a case report of acute myopia following topiramate administration. There are several reports of this side effect recently and fortunately all of them were reversible. In our case we tried again topiramate with very low dose and increase it very slowly, the patient was followed and she tolerated it well and didnt find ocular problem anymore. So it could be suggested that starting with lo...
full textTopiramate induced acute transient myopia: a case report
INTRODUCTION Topiramate is a sulfamate-substituted monosaccharide mainly used to treat epilepsy in children and adults and for prophylaxis of migraine. This article describes a case of topiramate induced acute transient myopia. The underlying mechanism and management is discussed. CASE PRESENTATION A 34-year-old female complained of sudden onset of blurred vision, 9 days prior to this she had...
full textacute myopia secondary to usage of topiramate: a case report
purpose: to present a case of acute myopia secondary to usage of topiramate. patient and findings: a 26-year-old female presented with 6-diopter myopia after two weeks of using topiramate for migraine headache. she improved after 3 days of cessation of this medicine. conclusion: when a patient present with acute onset visual loss secondary to refractive error, history of drug usage can help for...
full textAcute myopia induced by topiramate: report of a case and review of the literature.
Topiramate, a new anticonvulsant, is also used for the prophylaxis of migraine and cluster headache. A serious but not often discussed side effect of the drug is the development of acute myopia and acute angle-closure glaucoma in the early stage of therapy that subsides rapidly with prompt discontinuation. One such case is reported here and the relevant literature in this regard is also reviewed.
full textTopiramate-Induced Acute Bilateral Angle Closure Glaucoma and Transient Myopia: A Teaching Case Report
Topiramate is a sulfamate-substituted monosaccharide used in the treatment of epilepsy and migraines. It also has an off-label use in the treatment of bipolar disorder, depression and as a weight reduction agent, among other uses. With the growing off-label use of this oral medication, it is important to raise awareness within the medical community of the potentially blinding side effects of to...
full textTopiramate-Induced Acute Bilateral Angle Closure Glaucoma and Transient Myopia: A Teaching Case Report
Topiramate is a sulfamate-substituted monosaccharide used in the treatment of epilepsy and migraines. It also has an off-label use in the treatment of bipolar disorder, depression and as a weight reduction agent, among other uses. With the growing off-label use of this oral medication, it is important to raise awareness within the medical community of the potentially blinding side effects of to...
full textMy Resources
Journal title
volume 19 issue 1
pages 69- 101
publication date 2012-12-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023